The successful manufacture of your autologous cell or gene therapy relies on high-quality starting material. So you need an apheresis network that can provide it consistently on an ongoing basis. And do so while maintaining regulatory compliance.
Our Collection Network Management solution can give you peace of mind that your autologous apheresis network will deliver. And that issues will be resolved if they arise.
Our experience in collection network management extends to allogeneic cell therapies, too. Collection Center Network Management is included as part of our Allogeneic Cell Sourcing service.
“There are great partners out there who can provide the support and training necessary to minimize the burden on apheresis centers. NMDP BioTherapies℠ is an example of an organization that has taken the lead and is efficiently building and managing these networks.”
– Usman “Oz” Azam
Formerly President and CEO
Our team monitors continual compliance with therapy-specific needs
Our Collection Network Liaisons and Managers remain your point of contact even after we help you onboard your apheresis network. Each team member is experienced in apheresis collection as a cellular starting material.
Our team has extensive experience onboarding, training and managing apheresis centers in the United States and Europe.
Typical Collection Network Management services
Ongoing collection support
Answer questions from centers as they arise and monitor trends to provide recommendations on additional training or process changes; provide an on-call team member on day of collection.
Update centers as needed on industry standards.
Provide refresher training when deemed needed or at a regular cadence as requested by the client.
Routine center management
Track key performance indicators (KPIs) and center changes, such as personnel and equipment.
Assist client quality teams in researching quality concerns and deviations.
Ongoing management of your apheresis collection network can seem daunting. And time consuming. Our team can help. Connect with us to discuss your needs.
Can NMDP BioTherapies manage the apheresis centers that are collecting starting material for my therapy?
Yes. Our extensive team is experienced in apheresis collection for cellular starting material.
How will I know the apheresis centers in my network are meeting quality and consistency expectations as they collect cells for cell therapy manufacturing?
Prior to the first collection, develop key collection attributes that can be tracked with each collection. Our Collection Center Network Liaisons and Managers can work with you to develop appropriate KPIs to manage your collections.
Can you support Collection Network Management outside of the U.S.? For example, in Europe, Asia, Japan and Australia?
Our team is most experienced in apheresis network management in the U.S. and Europe. We have some limited experience outside these regions. Please contact us to discuss your specific needs.
We understand the importance of consistent, high-quality cellular starting material for autologous cell therapies. We would value the opportunity to discuss your needs and how we can help.